---
title: "Psychosocial profile in adults with congenital heart disease by documented anxiety disorder history"
id: "plos-one-21-psychosocial-profile-of-adults-with-congenital-heart-disease-according-to"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-21-psychosocial-profile-of-adults-with-congenital-heart-disease-according-to"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0360616"
published_at: "2026-10-22T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Psychosocial profile in adults with congenital heart disease by documented anxiety disorder history
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-21-psychosocial-profile-of-adults-with-congenital-heart-disease-according-to
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0360616)
- **Published At:** 2026-10-22T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- This cross-sectional study enrolled 45 adults with **congenital heart disease** recruited consecutively at a tertiary outpatient clinic between January and June 2023. - Participants were divided by presence (n=21) or absence (n=24) of a documented history of **anxiety disorders** recorded in the electronic medical record prior to study inclusion. - Psychosocial instruments included the EuroQol-5D-3L (EQ-5D-3L) with EQ-VAS, Rosenberg Self-Esteem Scale (RSES), State–Trait Anxiety Inventory (**STAI**), and Beck Depression Inventory-II (**BDI-II**). - Investigators adjusted multivariable logistic regression models for sex, NYHA functional class, and CHD complexity to assess associations between psychosocial measures and documented anxiety history. - The cohort with documented anxiety history had more frequent NYHA class II–IV, greater limitations in usual activities, higher EQ-5D anxiety/depression domain scores, worse self-rated health, higher trait anxiety scores, and higher depressive symptom severity on **BDI-II** in unadjusted comparisons. - After multivariable adjustment, higher **BDI-II** scores were associated with a documented history of anxiety (OR 1.14 per point, 95% CI 1.05–1.28), and higher EQ-VAS scores were inversely associated (OR 0.64, 95% CI 0.38–0.97). - **STAI-State**, **STAI-Trait**, and **RSES** were not significantly associated with documented anxiety history in adjusted analyses. - The study did not consistently capture diagnostic timing, diagnosing clinician, diagnostic criteria, prior treatments, or psychiatric care setting, and these variables were therefore not included in analyses. - Data sharing is restricted by ethical approval; data are available upon reasonable request to the institutional ethics committee as stated by the authors.
## Clinical Analysis & Structured Key Points
Psychosocial profile of adults with Congenital Heart Disease according to documented history of anxiety disorders | PLOS One Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Article Authors Metrics Comments Media Coverage Reader Comments Figures Figures Abstract Background Adults with congenital heart disease (CHD) may experience substantial psychological distress. This study evaluated whether a documented history of anxiety disorders is associated with a distinct psychosocial profile in adults with CHD. Methods In this cross-sectional study, 45 adults with CHD were included: 21 with a documented history of anxiety disorders and 24 without. Psychosocial assessment included the EuroQol-5D-3L (EQ-5D-3L), Rosenberg Self-Esteem Scale (RSES), State–Trait Anxiety Inventory (STAI), and Beck Depression Inventory-II (BDI-II). Associations between psychosocial measures and documented anxiety history were assessed using multivariable logistic regression adjusted for sex, NYHA functional class, and CHD complexity. Moderate depression was additionally assessed using univariable logistic regression. Results Mean age was 35 ± 9 years in participants with a documented history of anxiety disorders and 31 ± 11 years in those without ( P = 0.230); males accounted for 33% and 62%, respectively ( P = 0.052). NYHA functional class II–IV was more frequent among participants with a documented history of anxiety disorders (67% vs. 25%; P = 0.018). Compared with those without a documented anxiety history, participants with anxiety history reported greater limitations in usual activities ( P = 0.021), higher anxiety/depression scores on the EQ-5D-3L ( P = 0.023), poorer self-rated health ( P = 0.038), higher trait anxiety (31.2 ± 5.8 vs. 26.5 ± 5.2; P = 0.008), and greater depressive symptom severity (BDI-II median 19 vs. 3; P = 0.001). Self-esteem was also higher (RSES median 27 vs. 25; P = 0.006). After adjustment, BDI-II scores were positively associated with a documented history of anxiety disorders (OR 1.14, 95% CI 1.05–1.28; P = 0.011), while EQ-5D VAS scores were inversely associated (OR 0.64, 95% CI 0.38–0.97; P = 0.048). STAI-State, STAI-Trait, and RSES scores were not significantly associated with anxiety history. None of the variables assessed in the univariable analysis was significantly associated with moderate depression. Conclusions In adults with CHD, a documented history of anxiety disorders was associated with greater depressive symptom severity and poorer self-rated health after adjustment for relevant clinical factors. Citation: Martínez-Quintana E, García-Suárez MI, Alcántara-Castellano M, González-Martín JM, Rodríguez-González F (2026) Psychosocial profile of adults with Congenital Heart Disease according to documented history of anxiety disorders. PLoS One 21(10): e0360616. https://doi.org/10.1371/journal.pone.0360616 Editor: Vincenzo Lionetti, Scuola Superiore Sant’Anna, ITALY Received: May 4, 2026; Accepted: September 29, 2026; Published: October 22, 2026 Copyright: © 2026 Martínez-Quintana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: The dataset underlying this study contains sensitive clinical information from adults with congenital heart disease that could potentially permit participant re-identification despite de-identification. Therefore, public data sharing is subject to ethical restrictions established by the Research Ethics Committee (CEIm; approval code: 2022-033-1). Data are available upon reasonable request. Data access requests may be submitted to: CEI/CEIm Provincial de Las Palmas Hospital Universitario de Gran Canaria Dr. Negrín. Barranco de la Ballena s/n. Research Unit. 35019 Las Palmas de Gran Canaria, Spain Email: ceimprovlpa.scs@gobiernodecanarias.org . Funding: The author(s) received no specific funding for this work. Competing interests: No authors have competing interests. 1. Introduction Psychological disorders are highly prevalent among individuals with chronic illnesses and represent an important determinant of quality of life and clinical outcomes. Conditions such as diabetes, cardiovascular disease, and autoimmune disorders are frequently associated with sustained psychological distress, including anxiety, depression, and chronic stress. These difficulties may arise from the long-term nature of the disease, treatment burden, and uncertainty regarding prognosis, and may adversely affect symptom perception, coping behaviors, treatment adherence, and healthcare use [ 1 ]. Cardiovascular disease may impose not only physiological limitations but also substantial psychosocial challenges. Fear of adverse cardiovascular events, restrictions in physical activity, and the need for long-term medical follow-up may contribute to chronic stress, reduced perceived control, social withdrawal, and impaired interpersonal relationships [ 2 , 3 ]. Congenital heart disease (CHD) comprises a heterogeneous group of structural cardiac abnormalities present at birth. Its reported incidence ranges from 4 to 50 per 1,000 live births [ 4 , 5 ]. Advances in diagnosis, surgical treatment, and long-term care have enabled more than 90% of affected individuals to survive into adulthood [ 6 ]. Nevertheless, many adults with CHD require repeated interventions, implanted cardiac devices, or lifelong medical treatment and surveillance. In addition, functional and neurodevelopmental difficulties, including language impairments, attentional deficits, and behavioral problems, may contribute to the increased prevalence of anxiety and mood disorders reported in this population, affecting approximately one-third of adults with CHD [ 7 – 14 ]. These findings support the integration of psychological assessment into routine CHD care. Despite the high prevalence of anxiety among adults with CHD, its identification and characterization in clinical practice remain heterogeneous. Most previous studies have relied on symptom-based psychometric instruments administered at a single point in time, whereas fewer have examined the clinical relevance of a previously documented history of anxiety recorded in the medical chart. In routine practice, psychiatric history is frequently considered during clinical decision-making and may provide complementary longitudinal information regarding psychological vulnerability. However, its interpretation is also influenced by access to mental healthcare, diagnostic practices, and the completeness of medical records. It therefore remains unclear whether adults with CHD and a documented history of anxiety exhibit a distinct psychosocial profile compared with those without such a history. The aim of this study was to compare clinical characteristics, health-related quality of life, and psychological outcomes in adults with CHD according to the presence or absence of a documented history of anxiety. We hypothesized that patients with a documented history of anxiety would exhibit greater psychological symptom burden and poorer self-perceived health and functional status. 2. Methods 2.1. Study design and participants This observational, analytical, cross-sectional study was conducted at a tertiary referral outpatient clinic specializing in CHD. Adult patients aged 18 years or older with a confirmed diagnosis of CHD were consecutively recruited during routine follow-up visits between January 1 and June 1, 2023. The diagnosis of CHD was established through a comprehensive review of medical records, including previous imaging studies, such as echocardiography, cardiac magnetic resonance imaging, or computed tomography, together with surgical reports when available. CHD complexity was classified according to established clinical criteria [ 15 ]. Participants were stratified according to the presence or absence of a documented history of anxiety disorder recorded in the electronic medical record before study inclusion. Patients classified as cases had a documented diagnosis of an anxiety disorder, irrespective of current or previous pharmacological treatment. Controls had no documented history of anxiety disorder and no prior use of anxiolytic medication. The diagnosis of anxiety had been established during routine clinical care by the treating healthcare professional and was not reassessed for the purposes of this study. Information regarding the healthcare professional responsible for the diagnosis (e.g., psychiatrist, psychologist, cardiologist, or general practitioner), the diagnostic criteria used (e.g., Diagnostic and Statistical Manual of Mental Disorders or International Classification of Diseases ), and the exact date of diagnosis was not consistently available in the medical records. Consequently, these variables could not be included in the analyses. Anxiety symptoms reported during the study interview were recorded for descriptive purposes only and were not used to classify participants, thereby minimizing the risk of misclassification based on transient symptomatology. Patients were excluded if they had cognitive or neurological disorders that could interfere with questionnaire completion; severe psychiatric disorders other than anxiety; an acute cardiovascular event (including myocardial infarction, cardiac surgery, or heart failure decompensation) within the previous six months; pregnancy; inability to complete the questionnaires because of language, visual, or comprehension barriers; severe comorbid conditions limiting life expectancy; incomplete medical records; or insufficient information to determine psychiatric history. 2.2. Data collection Demographic, clinical, psychiatric, and socioeconomic information was collected through structured interviews and a review of the electronic medical records. Demographic variables included age and sex. Clinical variables comprised the type and complexity of CHD, New York Heart Association (NYHA) functional class, cardiovascular risk factors (systemic arterial hypertension, diabetes mellitus, dyslipidemia, and smoking status), the number of previous cardiac surgical procedures, and the presence of implantable cardiac devices, including pacemakers and implantable cardioverter-defibrillators. Psychiatric variables included documented psychiatric diagnoses and the use of anxiolytic medication. Information regarding the timing of the anxiety diagnosis, comorbid depression, antidepressant treatment, and previous psychological or psychiatric care was not systematically available and therefore could not be incorporated into the analyses. Socioeconomic variables included occupational status (employed, retired, homemaker, student, unemployed, or other) and educational level (primary education, secondary education/vocational training, or university education). The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Research Ethics Committee (CEIm; approval code: 2022-033-1). Written informed consent was obtained from all participants before enrolment. 2.3. Psychosocial assessment Psychosocial outcomes were evaluated using validated self-administered instruments assessing health-related quality of life, self-esteem, anxiety, and depressive symptoms. All questionnaires were completed during routine outpatient visits under standardized conditions. Health-related quality of life was assessed using the EuroQol-5D-3L (EQ-5D-3L), which evaluates five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each domain is scored across three levels of severity. Overall self-rated health was assessed using the EQ visual analogue scale (EQ-VAS). In accordance with the validated Spanish version used at our institution, participants rated their current health on a scale ranging from 0 (worst imaginable health state) to 10 (best imaginable health state) [ 16 , 17 ]. Self-esteem was assessed using the Rosenberg Self-Esteem Scale (RSES), a 10-item questionnaire evaluating global self-worth. Each item is scored on a four-point Likert scale, with higher scores indicating greater self-esteem [ 18 – 20 ]. Anxiety was assessed using the State–Trait Anxiety Inventory (STAI), which distinguishes state anxiety, reflecting transient emotional responses, from trait anxiety, representing a relatively stable predisposition to perceive situations as threatening. Each subscale consists of 20 items scored on a four-point Likert scale. Raw STAI-State and STAI-Trait scores were analysed without age- or sex-standardization [ 21 , 22 ]. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II), a 21-item questionnaire evaluating cognitive, affective, and somatic symptoms of depression. Each item is scored from 0 to 3, with higher total scores indicating greater depressive symptom severity. A BDI-II score >20 was selected to identify participants with at least moderate depressive symptoms according to the original instrument classification [ 23 , 24 ]. All questionnaires have been validated in Spanish populations and are considered appropriate for adults with chronic diseases. 2.4. Outcomes The primary objective of the study was to compare the psychosocial profile of adults with CHD according to the presence or absence of a documented history of anxiety disorders. The principal outcomes were trait anxiety, depressive symptom severity, self-esteem, and self-rated health. Secondary outcomes included state anxiety and each individual dimension of the EQ-5D-3L. For exploratory analyses, depressive symptoms were additionally dichotomized using a BDI-II score >20 to identify participants with at least moderate depressive symptoms. 2.5. Statistical analysis Continuous variables were summarized as mean ± standard deviation (SD) or median (interquartile range [IQR]), according to their distribution. Normality was assessed using the Shapiro–Wilk test. Categorical variables were presented as absolute and relative frequencies (percentages). Between-group differences in continuous variables were assessed using Student’s t test for normally distributed variables and the Mann–Whitney U test for non-normally distributed variables. Categorical variables were compared using the chi-square test or Fisher’s exact test, as appropriate. To assess the associations between psychological, health-related, and quality-of-life scale scores and case–control status, separate multivariable logistic regression models were fitted for each quantitative scale score. Case–control status was specified as the binary dependent variable, with cases considered the event. All models were adjusted a priori for sex, New York Heart Association (NYHA) functional class, and CHD complexity. For each scale score, the regression coefficient (β), standard error (SE), odds ratio (OR), 95% confidence interval (CI), and P value were estimated. Model fit was assessed using the Akaike information criterion (AIC), and discriminative performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC). The association between moderate depression and age, sex, NYHA functional class, and CHD complexity was evaluated using logistic regression, with moderate depression specified as the binary outcome. Univariable logistic regression models were initially fitted for each candidate variable. A multivariable model including age, sex, NYHA functional class, and CHD complexity was subsequently fitted. Given the small sample size and the limited number of participants with moderate depression (12 of 45 participants), an additional parsimonious exploratory multivariable model including sex and NYHA functional class was fitted to reduce model complexity. This model was considered a sensitivity analysis and should be interpreted as exploratory. Odds ratios and 95% CIs were reported for all models. Model fit was assessed using the AIC, and discriminative performance was evaluated using the AUC-ROC. All statistical tests were two-sided, and a P value <0.05 was considered statistically significant. Statistical analyses were performed using R software, version 4.6.1 (R Core Team, 2026). 3. Results A total of 45 adults with CHD were included in the study, comprising 21 patients with a documented history of anxiety and 24 without such a history. The spectrum of CHD was heterogeneous in both groups. Among controls, the most frequent diagnoses were tetralogy of Fallot, atrial septal defect, and coarctation of the aorta, whereas tetralogy of Fallot, atrioventricular septal defects, and transposition of the great arteries predominated among patients with a documented history of anxiety. Although severe CHD was numerically more common in the anxiety group (38.1% vs. 16.7%), no statistically significant differences in CHD complexity were observed between groups (p = 0.195). Baseline demographic and clinical characteristics are summarized in Table 1 . There were no significant differences in age, sex distribution, cardiovascular risk factors, previous cardiac surgery, or the presence of implantable cardiac devices. Occupational status and educational level were also comparable between groups. However, patients with a documented history of anxiety were significantly more likely to present with New York Heart Association (NYHA) functional class II–IV than controls (67% vs. 25%, p = 0.018). Download: PNG larger image TIFF original image Table 1. Baseline clinical characteristics and psychological outcomes according to documented history of anxiety. https://doi.org/10.1371/journal.pone.0360616.t001 Regarding health-related quality of life, patients with a documented history of anxiety reported significantly greater limitations in usual activities (43% vs. 12%, p = 0.021), a higher frequency of problems in the anxiety/depression dimension of the EQ-5D-3L (71% vs. 33%, p = 0.023), and poorer self-rated health as measured by the EQ-5D visual analogue scale (6.8 ± 1.9 vs. 8.0 ± 1.7, p = 0.038). No statistically significant differences were observed in the mobility, self-care, or pain/discomfort dimensions. Psychological assessment revealed significantly higher trait anxiety among patients with a documented history of anxiety compared with controls (STAI-T: 31.2 ± 5.8 vs. 26.5 ± 5.2, p = 0.008), whereas state anxiety did not differ between groups (STAI-S: 51.1 ± 5.7 vs. 51.2 ± 6.3, p = 0.967). Depressive symptom severity was also substantially greater in the anxiety group (BDI-II median 19 [interquartile range, 6–27] vs. 3 [interquartile range, 3–7.5]; p = 0.001), corresponding to mild depressive symptoms among cases and minimal depressive symptoms among controls. Self-esteem scores were modestly but significantly higher in patients with a documented history of anxiety (median 27 vs. 25, p = 0.006), although both groups remained within the range generally considered to represent moderate self-esteem. As shown in Table 2 , after adjustment for sex, NYHA functional class, and CHD complexity, the Beck Depression Inventory-II score was positively associated with a documented history of anxiety disorders (OR 1.14, 95% CI 1.05–1.28; P = 0.011), indicating higher odds of having a documented history of anxiety disorders with increasing depression scores. In contrast, the STAI-State score was not significantly associated with a documented history of anxiety disorders (OR 0.96, 95% CI 0.83–1.09; P = 0.541). The STAI-Trait score (OR 1.16, 95% CI 1.00–1.38; P = 0.069) and the Rosenberg Self-Esteem Scale score (OR 1.35, 95% CI 1.00–1.94; P = 0.063) showed positive associations that did not reach statistical significance. The EQ-5D VAS score was inversely associated with a documented history of anxiety disorders (OR 0.64, 95% CI 0.38–0.97; P = 0.048)
## Related Clinical Research

- [Multimodal extraction of heart disease risk factors from free-text and structured records using Li](https://medichelpline.com/clinical-feed/plos-one-0-leveraging-free-text-clinical-records-for-heart-disease-classification-through.md)
- [Impact of Nighttime Light Exposure on Heart Health and Disease Risk](https://medichelpline.com/clinical-feed/medical-news-today-0-nighttime-light-exposure-may-alter-the-heart-and-increase-disease-risk.md)
- [InControl web platform pilot assessing usability and feasibility in older adults with chronic musc](https://medichelpline.com/clinical-feed/plos-one-13-feasibility-acceptability-and-usability-of-incontrol-web-platform-intervention.md)
- [More REM (dream) sleep linked to lower risk of 83 diseases—UK Biobank study](https://medichelpline.com/clinical-feed/medical-news-today-0-more-dream-sleep-linked-to-lower-risk-of-83-diseases-including-diabetes.md)
- [MGST3 marks a mitochondrial-health–linked M2-like macrophage state in atherosclerosis](https://medichelpline.com/clinical-feed/frontiers-in-immunology-7-mgst3-defines-a-mitochondrial-health-associated-m2-macrophage-state-in.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.